Luxembourg has a young and ambitious BioHealth and Life Sciences community, which has identified four aspects of personalised medicine where the country has significant potential: digital health, neurodegenerative diseases, molecular diagnostics and immune-oncology. Luxembourg is also home to a group of dynamic companies specialised in the health sciences and technologies field.
This relatively young sector has experienced strong development over the past few years, and is currently specialising in the following fields:
– Personalised medicine
The government’s firm commitment to establishing Luxembourg as an attractive destination for health sciences research and innovation is backed by substantial public investment and a supportive business environment.
The further development of the sector is being supported by an ambitious national action plan, which aims to develop the country as a centre of excellence in molecular diagnostics, the main pillar of personalised medicine.